Dividend stocks: 3 FTSE 100 bargains I’d buy today

G A Chester highlights three FTSE 100 dividend stocks he sees as strong candidates to maintain their payouts in the current dividend mayhem.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Dividend stocks are proving problematic right now. Of course, dividends are never guaranteed, even at the best of times. But with companies currently intent on conserving cash, due to the uncertain duration of the Covid-19 pandemic, it’s hard to say any dividend is safe.

Nevertheless, some firms appear better placed than others to maintain their payouts. Here are three FTSE 100 dividend stocks I think are strong candidates. I see them as bargain buys today.

Reaffirmed dividend intention

Coca-Cola HBC (LSE: CCH) is one of the largest bottling and distribution partners of The Coca-Cola Company. Due to its brilliant brands, it’s among my favourite dividend stocks.

Following another strong set of annual results in February, CCH issued a Covid-19 update on 27 March. It told us that in markets with heavy lockdowns, “demand in the ‘out of home’ channel has been severely affected.”

However, management said it’s taking actions to help “support our profitability.” It also reassured investors: “We benefit from a very strong balance sheet.” As a result, the board reaffirmed its “intention to propose an ordinary dividend of €0.62 per share.” This is an 8.8% increase on the previous year, and translates to 53.9p per share at current exchange rates.

CCH’s share price is 1,928p, as I’m writing, which is a 37% discount to its 52-week high. Due to the fall in the share price, the prospective dividend yield is an historically generous 2.8%. Meanwhile, the forward price-to-earnings (P/E) ratio is an historically cheap 17.1.

One of the most popular dividend stocks

As far as we know, there’s been no negative impact from Covid-19 on the business of drugs giant GlaxoSmithKline(LSE: GSK). In fact, its recent news releases could be positive for the company, and the wider world.

On 6 April, it announced a collaboration with US firm Vir Biotechnology to find coronavirus solutions. And earlier this week, a collaboration with French big pharma peer Sanofi to develop a Covid-19 vaccine was added.

GSK has long been one of the FTSE 100’s most popular dividend stocks. This despite its payout having been pegged at 80p per share for a number of years, due to a challenging period of patent expiries. In its annual results in February, it said it expects to maintain the payout at 80p for 2020.

At a share price of 1,654p (10% below its 52-week high), the dividend yield is a chunky 4.8%. The forward P/E of 14.5 is also attractive, in my view.

Utility dividend stocks

Regulated utilities, if well-managed, can be reliable safe-haven dividend stocks. I like the look of water company Severn Trent (LSE: SVT) right now.

On 28 January, it announced its new dividend policy for the next five years. Namely, “growth of at least CPIH” inflation. It said it expects to pay 100.08p per share for its financial year ended 31 March.

In a trading statement on 31 March, it said: “We have good financial resilience with which to manage the impact of the [Covid-19] outbreak.” And while it added “we will continue to closely monitor our cash flows,” there was no mention of any change to dividend expectations.

At a share price of 2,346p (13% below its 52-week high), the dividend yield is 4.3%, and the P/E is 17.4. I feel this is another attractive dividend stock to buy today.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »